{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:30:16Z","timestamp":1790278216626,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-024-01176-3","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T02:50:41Z","timestamp":1735354241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis \u2013 SPARTAN 2024 Annual Meeting Proceedings"],"prefix":"10.1007","volume":"27","author":[{"given":"Patricia","family":"Remalante-Rayco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"issue":"2","key":"1176_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00281-020-00833-w","volume":"43","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Boroojeni SF, Haroon N. Aberrant antigen processing and presentation: key pathogenic factors leading to immune activation in Ankylosing spondylitis. Semin Immunopathol. 2021;43(2):245\u201353.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"1176_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11926-021-00995-y","volume":"23","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Haroon N. Recent updates in the immunopathology of type 3 immunity-mediated Enthesitis. Curr Rheumatol Rep. 2021;23(5):31.","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"1176_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrrheum.2012.42","volume":"8","author":"L Van Praet","year":"2012","unstructured":"Van Praet L, Jacques P, Van Den Bosch F, Elewaut D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):288\u201395.","journal-title":"Nat Rev Rheumatol"},{"key":"1176_CR4","doi-asserted-by":"publisher","first-page":"101607","DOI":"10.1016\/j.smim.2022.101607","volume":"58","author":"D Mauro","year":"2021","unstructured":"Mauro D, Nakamura A, Haroon N, Ciccia F. The gut-enthesis axis and the pathogenesis of Spondyloarthritis. Semin Immunol. 2021;58:101607.","journal-title":"Semin Immunol"},{"key":"1176_CR5","doi-asserted-by":"crossref","unstructured":"Wang Q, Xu R. Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis. BMC Genomics. 2019;20(1).","DOI":"10.1186\/s12864-019-5510-y"},{"issue":"551","key":"1176_CR6","doi-asserted-by":"publisher","first-page":"eaax2220","DOI":"10.1126\/scitranslmed.aax2220","volume":"12","author":"S-C Choi","year":"2020","unstructured":"Choi S-C, Brown J, Gong M, Ge Y, Zadeh M, Li W, et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med. 2020;12(551):eaax2220.","journal-title":"Sci Transl Med"},{"key":"1176_CR7","doi-asserted-by":"crossref","unstructured":"Yu D, Du J, Pu X, Zheng L, Chen S, Wang N et al. The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis. Front Cell Infect Microbiol. 2022;11.","DOI":"10.3389\/fcimb.2021.763507"},{"issue":"10","key":"1176_CR8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/art.42616","volume":"75","author":"Y Luo","year":"2023","unstructured":"Luo Y, Tong Y, Wu L, Niu H, Li Y, Su LC, et al. Alteration of gut microbiota in individuals at <\u2009scp\u2009>\u2009high-risk\u2009for rheumatoid arthritis Associated with disturbed metabolome and the initiation of arthritis through the triggering of Mucosal Immunity Imbalance. Arthritis Rheumatol. 2023;75(10):1736\u201348.","journal-title":"Arthritis Rheumatol"},{"key":"1176_CR9","doi-asserted-by":"crossref","unstructured":"Seymour BJ, Trent B, Allen BE, Berlinberg AJ, Tangchittsumran J, Jubair WK et al. Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice. J Clin Invest. 2024;134(4).","DOI":"10.1172\/JCI167671"},{"key":"1176_CR10","doi-asserted-by":"publisher","first-page":"100050","DOI":"10.1016\/j.jtauto.2020.100050","volume":"3","author":"F Motta","year":"2020","unstructured":"Motta F, Carena MC, Selmi C, Vecellio M. MicroRNAs in ankylosing spondylitis: function, potential and challenges. J Transl Autoimmun. 2020;3:100050.","journal-title":"J Transl Autoimmun"},{"key":"1176_CR11","doi-asserted-by":"publisher","first-page":"106773","DOI":"10.1016\/j.intimp.2020.106773","volume":"87","author":"Y Huang","year":"2020","unstructured":"Huang Y, Feng F, Huang Q, Zheng S, Huang Z, Deng W, et al. Proteomic analysis of serum-derived extracellular vesicles in ankylosing spondylitis patients. Int Immunopharmacol. 2020;87:106773.","journal-title":"Int Immunopharmacol"},{"key":"1176_CR12","doi-asserted-by":"publisher","first-page":"2924935","DOI":"10.1155\/2021\/2924935","volume":"2021","author":"J Wieli\u0144ska","year":"2021","unstructured":"Wieli\u0144ska J, Crossland RE, \u0141acina P, \u015awierkot J, Bugaj B, Dickinson AM, et al. Exploring the Extracellular vesicle MicroRNA expression repertoire in patients with rheumatoid arthritis and ankylosing spondylitis treated with TNF inhibitors. Dis Markers. 2021;2021:2924935.","journal-title":"Dis Markers"},{"issue":"11","key":"1176_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/ard-2022-223791","volume":"82","author":"F Tavasolian","year":"2023","unstructured":"Tavasolian F, Lively S, Pastrello C, Tang M, Lim M, Pacheco A, et al. Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis. Ann Rheum Dis. 2023;82(11):1429\u201343.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1176_CR14","doi-asserted-by":"publisher","first-page":"35521","DOI":"10.1038\/srep35521","volume":"6","author":"J Mahnke","year":"2016","unstructured":"Mahnke J, Schumacher V, Ahrens S, K\u00e4ding N, Feldhoff LM, Huber M, et al. Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism. Sci Rep. 2016;6(1):35521.","journal-title":"Sci Rep"},{"issue":"12","key":"1176_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012;61(12):1693\u2013700.","journal-title":"Gut"},{"issue":"12","key":"1176_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","volume":"15","author":"J Sieper","year":"2019","unstructured":"Sieper J, Poddubnyy D, Miossec P. The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis. Nat Rev Rheumatol. 2019;15(12):747\u201357.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"1176_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/ard-2022-223757","volume":"82","author":"K Venken","year":"2023","unstructured":"Venken K, Jarlborg M, Decruy T, Mortier C, Vlieghe C, Gilis E, et al. Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis. Ann Rheum Dis. 2023;82(8):1076\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1176_CR18","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65(10):2645\u201354.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1176_CR19","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/annrheumdis-2019-215427","volume":"78","author":"LM \u00d8rnbjerg","year":"2019","unstructured":"\u00d8rnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, et al. Treatment response and drug retention rates in 24 195 biologic-na\u00efve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Ann Rheum Dis. 2019;78(11):1536\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1176_CR20","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1038\/s41591-023-02613-z","volume":"29","author":"OV Britanova","year":"2023","unstructured":"Britanova OV, Lupyr KR, Staroverov DB, Shagina IA, Aleksandrov AA, Ustyugov YY, et al. Targeted depletion of TRBV9\u2009+\u2009T cells as immunotherapy in a patient with ankylosing spondylitis. Nat Med. 2023;29(11):2731\u20136.","journal-title":"Nat Med"},{"issue":"12","key":"1176_CR21","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1002\/eji.1830211202","volume":"21","author":"G Chiocchia","year":"1991","unstructured":"Chiocchia G, Boissier MC, Fournier C. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur J Immunol. 1991;21(12):2899\u2013905.","journal-title":"Eur J Immunol"},{"issue":"5","key":"1176_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2337\/db11-0867","volume":"61","author":"Z Liu","year":"2012","unstructured":"Liu Z, Cort L, Eberwine R, Herrmann T, Leif JH, Greiner DL, et al. Prevention of type 1 diabetes in the rat with an allele-specific anti-T-cell receptor antibody: V\u03b213 as a therapeutic target and biomarker. Diabetes. 2012;61(5):1160\u20138.","journal-title":"Diabetes"},{"issue":"12","key":"1176_CR23","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/nm.4444","volume":"23","author":"PM Maciocia","year":"2017","unstructured":"Maciocia PM, Wawrzyniecka PA, Philip B, Ricciardelli I, Akarca AU, Onuoha SC, et al. Targeting the T cell receptor \u03b2-chain constant region for immunotherapy of T cell malignancies. Nat Med. 2017;23(12):1416\u201323.","journal-title":"Nat Med"},{"key":"1176_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1126\/scitranslmed.abd3595","volume":"13","author":"S Paul","year":"2021","unstructured":"Paul S, Pearlman AH, Douglass J, Mog BJ, Hsiue EH, Hwang MS, et al. TCR \u03b2 chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021;13:584.","journal-title":"Sci Transl Med"},{"issue":"4","key":"1176_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1399-0039.2002.600404.x","volume":"60","author":"E May","year":"2002","unstructured":"May E, Dulphy N, Frauendorf E, Duchmann R, Bowness P, Lopez de Castro JA, et al. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens. 2002;60(4):299\u2013308.","journal-title":"Tissue Antigens"},{"issue":"4","key":"1176_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.40028","volume":"69","author":"M Faham","year":"2017","unstructured":"Faham M, Carlton V, Moorhead M, Zheng J, Klinger M, Pepin F, et al. Discovery of T cell receptor \u03b2 motifs specific to HLA-B27-Positive Ankylosing spondylitis by Deep Repertoire sequence analysis. Arthritis Rheumatol. 2017;69(4):774\u201384.","journal-title":"Arthritis Rheumatol"},{"issue":"7941","key":"1176_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","volume":"612","author":"X Yang","year":"2022","unstructured":"Yang X, Garner LI, Zvyagin IV, Paley MA, Komech EA, Jude KM, et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature. 2022;612(7941):771\u20137.","journal-title":"Nature"},{"issue":"1","key":"1176_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S2665-9913(22)00334-4","volume":"5","author":"T Macleod","year":"2023","unstructured":"Macleod T, Bridgewood C, McGonagle D. Role of neutrophil interleukin-23 in spondyloarthropathy spectrum disorders. Lancet Rheumatol. 2023;5(1):e47\u201357.","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"1176_CR29","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183(6):2593\u2013603.","journal-title":"J Exp Med"},{"issue":"6","key":"1176_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/gene.2010.17","volume":"11","author":"JJ Pointon","year":"2010","unstructured":"Pointon JJ, Harvey D, Karaderi T, Appleton LH, Farrar C, Stone MA, et al. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun. 2010;11(6):490\u20136.","journal-title":"Genes Immun"},{"issue":"6","key":"1176_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/ni1460","volume":"8","author":"S LeibundGut-Landmann","year":"2007","unstructured":"LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8(6):630\u20138.","journal-title":"Nat Immunol"},{"issue":"2","key":"1176_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/ard-2022-223146","volume":"83","author":"HL Rosenzweig","year":"2024","unstructured":"Rosenzweig HL, Vance EE, Asare-Konadu K, Koney KV, Lee EJ, Deodhar AA, et al. Card9\/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Ann Rheum Dis. 2024;83(2):214\u201322.","journal-title":"Ann Rheum Dis"},{"key":"1176_CR33","doi-asserted-by":"publisher","first-page":"861459","DOI":"10.3389\/fimmu.2022.861459","volume":"13","author":"J Jiang","year":"2022","unstructured":"Jiang J, Zhan X, Qu H, Liang T, Li H, Chen L, et al. Upregulated of ANXA3, SORL1, and neutrophils may be key factors in the Progressionof Ankylosing Spondylitis. Front Immunol. 2022;13:861459.","journal-title":"Front Immunol"},{"issue":"6","key":"1176_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/gutjnl-2022-326917","volume":"72","author":"C Danne","year":"2023","unstructured":"Danne C, Michaudel C, Skerniskyte J, Planchais J, Magniez A, Agus A, et al. CARD9 in neutrophils protects from colitis and controls mitochondrial metabolism and cell survival. Gut. 2023;72(6):1081\u201392.","journal-title":"Gut"},{"issue":"1","key":"1176_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41467-018-07841-3","volume":"10","author":"Y Haberman","year":"2019","unstructured":"Haberman Y, Karns R, Dexheimer PJ, Schirmer M, Somekh J, Jurickova I, et al. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 2019;10(1):38.","journal-title":"Nat Commun"},{"issue":"6","key":"1176_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol. 2017;13(6):359\u201367.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1176_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11926-024-01136-x","volume":"26","author":"A Srinath","year":"2024","unstructured":"Srinath A, Nakamura A, Haroon N. Sequence of events in the pathogenesis of Axial spondyloarthritis: a current Review-2023 SPARTAN Meeting proceedings. Curr Rheumatol Rep. 2024;26(4):133\u201343.","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"1176_CR38","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3899\/jrheum.100200","volume":"37","author":"HA Chen","year":"2010","unstructured":"Chen HA, Chen CH, Lin YJ, Chen PC, Chen WS, Lu CL, et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol. 2010;37(10):2126\u201332.","journal-title":"J Rheumatol"},{"issue":"7","key":"1176_CR39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/art.40468","volume":"70","author":"X Li","year":"2018","unstructured":"Li X, Wang J, Zhan Z, Li S, Zheng Z, Wang T, et al. Inflammation intensity-dependent expression of Osteoinductive wnt proteins is critical for ectopic new bone formation in Ankylosing Spondylitis. Arthritis Rheumatol. 2018;70(7):1056\u201370.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1176_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/03009742.2017.1287305","volume":"47","author":"HT Liao","year":"2018","unstructured":"Liao HT, Lin YF, Tsai CY, Chou TC. Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis. Scand J Rheumatol. 2018;47(1):56\u201361.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1176_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00223-019-00542-z","volume":"105","author":"J Yang","year":"2019","unstructured":"Yang J, Xu S, Chen M, Yuan Y, Zhang X, Ma Y, et al. Serum sclerostin and bone morphogenetic Protein-2 levels in patients with Ankylosing spondylitis: a Meta-analysis. Calcif Tissue Int. 2019;105(1):37\u201350.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1176_CR42","doi-asserted-by":"publisher","first-page":"101491","DOI":"10.1016\/j.berh.2020.101491","volume":"33","author":"A Nakamura","year":"2019","unstructured":"Nakamura A, Talukdar A, Nakamura S, Pathan E, Haroon N. Bone formation in axial spondyloarthritis: is disease modification possible? Best Pract Res Clin Rheumatol. 2019;33(6):101491.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"1176_CR43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/mr\/roab057","volume":"32","author":"M Kusuda","year":"2022","unstructured":"Kusuda M, Haroon N, Nakamura A. Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches. Mod Rheumatol. 2022;32(3):484\u201392.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1176_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13075-021-02693-7","volume":"24","author":"Z Stavre","year":"2022","unstructured":"Stavre Z, Bridgewood C, Zhou Q, Maeda Y, Huang TT, Karman J, et al. A role for neutrophils in early enthesitis in spondyloarthritis. Arthritis Res Ther. 2022;24(1):24.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1176_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13075-020-02327-4","volume":"22","author":"E Christodoulou-Vafeiadou","year":"2020","unstructured":"Christodoulou-Vafeiadou E, Geka C, Ntari L, Kranidioti K, Argyropoulou E, Meier F, et al. Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis. Arthritis Res Ther. 2020;22(1):232.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1176_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/ard-2023-224107","volume":"83","author":"X Feng","year":"2024","unstructured":"Feng X, Wang C, Ji B, Qiao J, Xu Y, Zhu S, et al. CD_99 G1 neutrophils modulate osteogenic differentiation of mesenchymal stem cells in the pathological process of ankylosing spondylitis. Ann Rheum Dis. 2024;83(3):324.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1176_CR47","doi-asserted-by":"publisher","first-page":"e000399","DOI":"10.1136\/rmdopen-2016-000399","volume":"3","author":"WP Maksymowych","year":"2017","unstructured":"Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. Fat metaplasia on MRI of the sacroiliac joints increases the propensity for disease progression in the spine of patients with spondyloarthritis. RMD Open. 2017;3(1):e000399.","journal-title":"RMD Open"},{"issue":"1","key":"1176_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/annrheumdis-2011-200859","volume":"72","author":"WP Maksymowych","year":"2013","unstructured":"Maksymowych WP, Morency N, Conner-Spady B, Lambert RG. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis. 2013;72(1):23\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1176_CR49","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/annrheumdis-2015-208011","volume":"75","author":"PM Machado","year":"2016","unstructured":"Machado PM, Baraliakos X, van der Heijde D, Braun J, Landew\u00e9 R. MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis. Ann Rheum Dis. 2016;75(8):1486\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"616","key":"1176_CR50","doi-asserted-by":"publisher","first-page":"eabg1210","DOI":"10.1126\/scitranslmed.abg1210","volume":"13","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Zeng F, Nakamura S, Reid KT, Gracey E, Lim M, et al. Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease. Sci Transl Med. 2021;13(616):eabg1210.","journal-title":"Sci Transl Med"},{"issue":"9","key":"1176_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11926-022-01081-7","volume":"24","author":"B Wu","year":"2022","unstructured":"Wu B, Nakamura A. Deep insight into the role of MIF in Spondyloarthritis. Curr Rheumatol Rep. 2022;24(9):269\u201378.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"1176_CR52","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41423-024-01183-5","volume":"21","author":"A Nakamura","year":"2024","unstructured":"Nakamura A, Jo S, Nakamura S, Aparnathi MK, Boroojeni SF, Korshko M, et al. HIF-1\u03b1 and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis model. Cell Mol Immunol. 2024;21(7):770\u201386.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"1176_CR53","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.eururo.2018.09.030","volume":"75","author":"Q Fu","year":"2019","unstructured":"Fu Q, Xu L, Wang Y, Jiang Q, Liu Z, Zhang J, et al. Tumor-associated macrophage-derived Interleukin-23 interlinks kidney Cancer glutamine addiction with Immune Evasion. Eur Urol. 2019;75(5):752\u201363.","journal-title":"Eur Urol"},{"issue":"2","key":"1176_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.stemcr.2016.07.003","volume":"7","author":"Y Yao","year":"2016","unstructured":"Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF plays a key role in regulating tissue-specific chondro-osteogenic differentiation fate of human cartilage endplate stem cells under Hypoxia. Stem Cell Rep. 2016;7(2):249\u201362.","journal-title":"Stem Cell Rep"},{"issue":"8","key":"1176_CR55","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/ard-2023-224491","volume":"83","author":"P Lyu","year":"2024","unstructured":"Lyu P, Wen J, Zhang W, Liu N, Stolzer I, Gie\u00dfl A, et al. Expression of HIF1\u03b1 in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery. Ann Rheum Dis. 2024;83(8):984\u201397.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-024-01176-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:02:29Z","timestamp":1770750149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-024-01176-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1007\/s11926-024-01176-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"18 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not include any research involving human or animal subjects conducted by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"A Nakamura has received speaker and\/or consultation fees from Abbvie, Celltrion Healthcare, JAMP care, and Novartis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9"}}